Linthwaite Stephen Christopher
SEC CIK 1680808 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC. | Pres, CEO | 328.5K | — | — | 6 | 2021-08-20 | 2022-02-22 |
Most active insiders at LAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Casdin Partners GP, LLC | Dir, 10% | $11.41M | — |
| 2 | Casdin Eli | Dir, 10% | $1.37M | — |
| 3 | Casdin Partners Master Fund, L.P. | Dir, 10% | $1.12M | — |
| 4 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | $503.0K | — |
| 5 | Kim Hanjoon Alex | CFO | — | — |
| 6 | Mackay Sean | SVP, Chief Business Off | — | — |
| 7 | Cox Troy | Dir | — | — |
| 8 | Carey Thomas D. | Dir | — | — |
| 9 | Egholm Michael | Pres, CEO, Dir | — | — |
| 10 | Witney Frank | Dir | — | — |
Linthwaite Stephen Christopher made no open-market trades at LAB in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-24 | 2022-02-22 | LAB | STANDARD BIOTOOLS INC. | Linthwaite Stephen Christopher | Pres, CEO | F - Tax | $3.62 | -12.5K | 328.5K | -4% | -$45.1K |
| DM | 2022-02-24 | 2022-02-22 | LAB | STANDARD BIOTOOLS INC. | Linthwaite Stephen Christopher | Pres, CEO | M - OptEx | $0.00 | +22.4K | 326.3K | +7% | $0 |
| DM | 2021-11-24 | 2021-11-20 | LAB | STANDARD BIOTOOLS INC. | Linthwaite Stephen Christopher | Pres, CEO | M - OptEx | $0.00 | +22.4K | 318.8K | +8% | $0 |
| D | 2021-11-24 | 2021-11-20 | LAB | STANDARD BIOTOOLS INC. | Linthwaite Stephen Christopher | Pres, CEO | F - Tax | $4.49 | -11.3K | 315.2K | -3% | -$50.7K |
| DM | 2021-08-24 | 2021-08-20 | LAB | STANDARD BIOTOOLS INC. | Linthwaite Stephen Christopher | Pres, CEO | M - OptEx | $0.00 | +22.4K | 307.7K | +8% | $0 |
| D | 2021-08-24 | 2021-08-20 | LAB | STANDARD BIOTOOLS INC. | Linthwaite Stephen Christopher | Pres, CEO | F - Tax | $6.53 | -11.3K | 304.1K | -4% | -$73.7K |
Purchase Sale Sale after option exercise All abbreviations